SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001013762-23-007284
Filing Date
2023-10-27
Accepted
2023-10-27 16:08:49
Documents
2

Document Format Files

Seq Description Document Type Size
1 ADDITIONAL MATERIALS defa14a1023_inmedpharma.htm DEFA14A 50852
2 GRAPHIC tinmed_logo.jpg GRAPHIC 114250
  Complete submission text file 0001013762-23-007284.txt   209327
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-39685 | Film No.: 231355591
SIC: 2834 Pharmaceutical Preparations